HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 651212Erstellt: 25. Oktober 2026
Eperezolid → (S)-N-[[3-[3-Fluoro-4-[4-(hydroxyacetyl)-1-piperazinyl]phenyl]-2-oxo-5-oxazolidinyl]-methyl]acetamide N-oxide
https://huagongshe.com/reaction/651212
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Eperezolid | HCID 73214 | — |
| Edukt | 3-Hydroperoxyphthalic acid | HCID 19809706 | — |
| Lösungsmittel | Methanol | HCID 887 | — |
| Produkt | (S)-N-[[3-[3-Fluoro-4-[4-(hydroxyacetyl)-1-piperazinyl]phenyl]-2-oxo-5-oxazolidinyl]-methyl]acetamide N-oxide | HCID 86584035 | — |
Reaktionsschritte
(S)-N-[[3-[3-Fluoro-4-[4-(hydroxyacetyl)-1-piperazinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide (VIII-A, R1=COCH3, R2=H, X1=F, X2=H) (11.8 g) is dissolved in 200 mL of methanol. Monoperoxyphthalic acid, magnesium salt hexahydrate (80% pure, 18.5 g) is added and the resulting suspension is stirred at 25° C. for two hours. The reaction is filtered and the filtrate is concentrated to afford a white solid. This solid is chromatographed on silica gel using 20% methanol in chloroform as eluent to afford the N-oxide. Lyophilization of this material affords the purified product as a hydrate (9.5 g).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US06277985B1 |
|---|
| Quelldatensatz | uspto-grants-2001_08 |
|---|
| ORD ID | ord-47f5199f7b3f42a58388f844627c18c3 |
|---|
| Quellennotiz | uspto-grants-2001_08 |
|---|